Works matching IS 10538569 AND DT 2022 AND VI 31
Results: 188
Indirect covariate balance and residual confounding: An applied comparison of propensity score matching and cardinality matching.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1242, doi. 10.1002/pds.5510
- By:
- Publication type:
- Article
Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1272, doi. 10.1002/pds.5535
- By:
- Publication type:
- Article
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1262, doi. 10.1002/pds.5531
- By:
- Publication type:
- Article
Untitled.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1317, doi. 10.1002/pds.5543
- By:
- Publication type:
- Article
Partition testing for real‐world evidence studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1280, doi. 10.1002/pds.5540
- By:
- Publication type:
- Article
Development of a multivariate prediction model to identify individual case safety reports which require clinical review.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1300, doi. 10.1002/pds.5553
- By:
- Publication type:
- Article
Development and validation of case‐finding algorithms to identify acute pancreatitis in the Veterans Health Administration.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1294, doi. 10.1002/pds.5549
- By:
- Publication type:
- Article
Record linkage of claims and cancer registries data—Evaluation of a deterministic linkage approach based on indirect personal identifiers.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1287, doi. 10.1002/pds.5545
- By:
- Publication type:
- Article
Accuracy and validity of reported opioid prescription days' supply.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1253, doi. 10.1002/pds.5528
- By:
- Publication type:
- Article
Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1308, doi. 10.1002/pds.5524
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1129, doi. 10.1002/pds.5286
- Publication type:
- Article
A systematic review of whether COVID‐19 randomized controlled trials reported on demographic and clinical characteristics.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1219, doi. 10.1002/pds.5533
- By:
- Publication type:
- Article
Artificial intelligence in pharmacovigilance: Do we need explainability?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1311, doi. 10.1002/pds.5501
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1319, doi. 10.1002/pds.5290
- Publication type:
- Article
Use of prescription medications with cardiovascular adverse effects among older adults in the United States.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1027, doi. 10.1002/pds.5477
- By:
- Publication type:
- Article
Time‐related biases in perinatal pharmacoepidemiology: A systematic review of observational studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 12, p. 1228, doi. 10.1002/pds.5504
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
ISPE20 Author Index.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 679, doi. 10.1002/pds.5521
- Publication type:
- Article
ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 654, doi. 10.1002/pds.5520
- Publication type:
- Article
Antidepressant exposures associated with exploratory behavior among young children reported to United States poison control centers, 2000–2020.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1206, doi. 10.1002/pds.5534
- By:
- Publication type:
- Article
Adverse events in the digital age and where to find them.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1131, doi. 10.1002/pds.5532
- By:
- Publication type:
- Article
Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1182, doi. 10.1002/pds.5530
- By:
- Publication type:
- Article
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1140, doi. 10.1002/pds.5529
- By:
- Publication type:
- Article
Thromboembolic events after Ad.26.COV2.S COVID‐19 vaccine: Reports to the Vaccine Adverse Event Reporting System.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1174, doi. 10.1002/pds.5523
- By:
- Publication type:
- Article
A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulants.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1164, doi. 10.1002/pds.5514
- By:
- Publication type:
- Article
Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1153, doi. 10.1002/pds.5513
- By:
- Publication type:
- Article
Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1199, doi. 10.1002/pds.5493
- By:
- Publication type:
- Article
Antibacterial‐associated acute kidney injury among older adults: A post‐marketing surveillance study using the FDA adverse events reporting system.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1190, doi. 10.1002/pds.5486
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1217, doi. 10.1002/pds.5288
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
Metformin, pioglitazone and gout risk.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1127, doi. 10.1002/pds.5516
- By:
- Publication type:
- Article
Kidney function and prescribed dose in middle‐aged and older patients starting selective serotonin reuptake inhibitors.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1091, doi. 10.1002/pds.5515
- By:
- Publication type:
- Article
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1046, doi. 10.1002/pds.5509
- By:
- Publication type:
- Article
Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: An interrupted time series study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1039, doi. 10.1002/pds.5508
- By:
- Publication type:
- Article
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49–64 and 65–70 years old.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1056, doi. 10.1002/pds.5506
- By:
- Publication type:
- Article
Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1110, doi. 10.1002/pds.5503
- By:
- Publication type:
- Article
Risk of volume depletion events with concomitant use of sodium glucose co‐transporter 2 inhibitors and loop diuretics: A self‐controlled case series study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1102, doi. 10.1002/pds.5496
- By:
- Publication type:
- Article
Association between opioid therapy trajectories and potential opioid‐related adverse health events.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1075, doi. 10.1002/pds.5495
- By:
- Publication type:
- Article
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1015, doi. 10.1002/pds.5490
- By:
- Publication type:
- Article
Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L)1 monotherapies in routine practice.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1121, doi. 10.1002/pds.5487
- By:
- Publication type:
- Article
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 629, doi. 10.1002/pds.5519
- Publication type:
- Article
ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022: ORAL PRESENTATIONS.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 3, doi. 10.1002/pds.5518
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
ISPE20 Author Index.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 679, doi. 10.1002/pds.5521
- Publication type:
- Article
ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 654, doi. 10.1002/pds.5520
- Publication type:
- Article
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 629, doi. 10.1002/pds.5519
- Publication type:
- Article
ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022: ORAL PRESENTATIONS.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 3, doi. 10.1002/pds.5518
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
Validation of international classification of diseases, tenth revision, clinical modification diagnosis codes for heart failure subtypes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 992, doi. 10.1002/pds.5489
- By:
- Publication type:
- Article